- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2018 · career development · Young Investigator Award
Identifying mechanisms of resistance to DNA-damaging therapy in BRCA1/2-deficient metastatic breast cancer
Adrienne Waks · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Dissecting Response and Resistance to Immune and Targeted Therapies in Metastatic Melanoma Through Clinical Computational Oncology
David Liu · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Targeting the DNA Damage Response in Gastroesophageal Adenocarcinoma
Ankur Nagaraja · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Quantitative measurement of lenalidomide targets using a novel immunoaffinity enrichment and targeted mass spectrometry assay.
Adam Sperling · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Career Development Award
Screening MRI of the brain in patients with high-risk, metastatic breast cancer: A prospective study
Ayal Aizer · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · fellowship · ASH Research Training Award for Fellows (RTAF): Senior Awardees
ASH Research Training Award for Fellows (RTAF) 2018: Vidyasagar Koduri
Vidyasagar Koduri · Dana-Farber Cancer Institute · funded by American Society of Hematology
2018 · career development · Young Investigator Award
Dissecting Exhausted T Cell Subpopulations to Improve Anti-PD-1 Treatment of Metastatic Melanoma
Brian Miller · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · fellowship · AACR-AstraZeneca Fellowship in Lung Cancer Research
CARM1 as an epigenetic target for lung cancer immunotherapy
Sushil Kumar · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2018 · fellowship · ASH Research Training Award for Fellows (RTAF): Junior Awardees
ASH Research Training Award for Fellows (RTAF) 2018: Hojun Li
Hojun Li · Dana-Farber Cancer Institute · funded by American Society of Hematology
2018 · career development · Young Investigator Award
Epigenetic dissection of core-regulatory circuity in rhabdomyosarcoma
Adam Durbin · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018 · career development · Young Investigator Award
Investigating Transcriptional CDK13 in Melanoma
Megan Insco · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2018–2027 · research · R01
Advanced computational methods in analyzing high-throughput sequencing data
Heng Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2029 · cooperative agreement · U01
End-of-life care quality for adolescents and young adults with cancer: Including the patient voice in quality assessment
Jennifer W Mack · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2026 · research · R01
Comprehensive minimal residual disease tracking in cancer
Viktor Adalsteinsson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2029 · cooperative agreement · U24
Human Tumor Atlas Network: Data Coordinating Center
Robert C Gentleman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2026 · cooperative agreement · UH3
Administrative supplement to Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videosand Clinician Communication Training
James A. Tulsky · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U2C
Data Analysis Unit
Gad A Getz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Chemistry/Structural Core B
Nathanael Schiander Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2021 · cooperative agreement · U54
Project 2: EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options
Andrea C Enzinger · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Core C: Preclinical Models Core
Eric Alejandro Sweet-Cordero · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Project 3: Delineating and Drugging the Core Transcriptional Circuitry in Ewing Sarcoma
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Administrative Core
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Administrative Core (C1)
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U2C
Characterization Unit
David Liu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Understanding and Targeting Wild-Type SS18 Function and Stability in Synovial Sarcoma
Ali Shilatifard · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U2C
Administrative Core
Eliezer M Van Allen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Project 1: Targeted Protein Degradation of EWS-fusion Oncoproteins
John Hackett Bushweller · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U2C
Biospecimen Unit
Bruce E. Johnson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2019 · program · P01
Integrated genetic and phenotypic analysis of therapeutic resistance in chronic lymphocytic leukemia using functionalized lineage tracing
Catherine Ju-Ying Wu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
Project 2: Identification and Characterization of the Protein Interaction Network of EWS-FLI1
Miguel Nicolas Rivera · Dana-Farber Cancer Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U54
SS18-SSX-mediated Hijacking of mSWI/SNF (BAF) Complexes: Mechanisms and Functional Dependencies
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Prevention of HIV-1 transmission by small-molecule CD4-mimetic entry inhibitors
Navid Madani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · fellowship · CIHR Fellowship
The contribution of germline genomic variation to population-specific risk of EGFR mutation in lung cancers.
Jian Carrot-Zhang · Dana-Farber Cancer Institute · funded by Canadian Institutes of Health Research
2017–2022 · program · P01
Human Cancer Suppressor Functions of Protein Phosphatase 2A
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · research · R01
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers
Jinbo Chen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Transcriptional Regulation of the Androgen Receptor in Prostate Cancer
David Yoshio Takeda · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Investigating 53BP1 'dephosphorylation' as a critical determinant of PARP
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · research · R21
Immunotherapeutic Approaches Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
Donald W. Kufe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancer
Kent W Mouw · Dana-Farber Cancer Institute · funded by National Institutes of Health
